Day: June 28, 2023

SEATTLE, June 28, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today the appointment of Kim Drapkin and Scott Dylla, Ph.D. to its Board of Directors.  Ms. Drapkin will join the company’s audit and compensation committees and Dr. Dylla will join the compensation committee. “Kim and Scott’s extensive strategic, financial and clinical expertise, paired with their proven track records of leading commercial and development-stage biopharmaceutical companies, make them strong additions to our Board of Directors,” said Shawn Iadonato, Ph.D., Chief Executive Officer of Kineta. “I am looking forward to working closely with them as we enter this exciting time in Kineta’s evolution...

Leading Provider of Diversified Solutions, Aluf Tech, Drives Innovation and Egalitarianism FORT LAUDERDALE, Fla., June 28, 2023 (GLOBE NEWSWIRE) — Aluf Holdings, Inc. (“AHIX”) (“Aluf”) (OTC PINK: AHIX) a publicly traded company on the OTCBB, today announced its wholly owned subsidiary and technology division, Aluf Tech, LLC, is spearheading the Globalization and Revitalization Initiative, focused on developing cutting-edge business solutions, technology solutions, and life solutions for the 21st century. Emphasizing the importance of global unity, Aluf Tech aims to promote the continued progress of the international community as a whole, transcending the limitations of competition between nations. As a leading provider of diversified services, Aluf Tech enables businesses and individuals to thrive in a rapidly...

Liquidia exclusively licenses North American rights to L606, an inhaled formulation of treprostinil administered twice-daily with a short duration, next-generation nebulizer Liquidia funds $10 million upfront payment from finance agreement with HealthCare Royalty Pharmosa to receive up to $215 million in development and sales milestones for PAH and PH-ILD indications, $10 million for each additional approved indication and additional product, and royalties on net sales of L606 Creates industry leading portfolio in rapidly expanding market for inhaled treprostinil Liquidia to host webcast today at 8:30 a.m. Eastern TimeMORRISVILLE, N.C., June 28, 2023 (GLOBE NEWSWIRE) — Liquidia Corporation (NASDAQ: LQDA) (Liquidia or the Company) and Pharmosa Biopharm (Pharmosa) today announced that they have entered into an exclusive licensing...

MoonLake Immunotherapeutics Announces Pricing of $400 Million Upsized Public Offering of Class A Ordinary Shares ZUG, Switzerland, June 28, 2023 – MoonLake Immunotherapeutics (Nasdaq:MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory diseases, today announced the pricing on June 27, 2023 of its upsized underwritten public offering of 8,000,000 Class A ordinary shares at a public offering price per share of $50.00. The gross proceeds from the offering to MoonLake, before deducting the underwriting discounts and commissions and other offering expenses payable by MoonLake, are expected to be $400 million. In addition, MoonLake has granted the underwriters of the offering an option for a period of 30 days to purchase up to an additional 1,200,000 Class A ordinary shares at the...

SHENZHEN, China, June 28, 2023 (GLOBE NEWSWIRE) — Aurora Mobile Limited (NASDAQ: JG) (“Aurora Mobile” or the “Company”), a leading provider of customer engagement and marketing technology services in China, today announced that on June 27, 2023, the Listing Qualifications department of the Nasdaq Stock Market LLC (“Nasdaq”) approved the Company’s request to transfer the listing of the Company’s American Depositary Shares (the “ADSs”) from the Nasdaq Global Market to the Nasdaq Capital Market. The transfer is expected to take effect at the opening of business on June 29, 2023. The transfer of the Company’s listing to the Nasdaq Capital Market is not expected to have any impact on trading in the Company’s ADSs. The Company’s ADSs will continue to trade uninterruptedly under the symbol “JG.” The Nasdaq Capital Market operates in substantially...

NORDIC FIBREBOARD AS (reg nr11421437, address Rääma 31, Pärnu 80044) Extraordinary General Meeting of shareholders was held on Wednesday, 28th of June 2023 in Nordic Fibreboard AS office, at Rääma 31, Pärnu.  The general meeting started at 10.00 and ended at 10:20 At the meeting  2 612 775 votes were present which represent  58,07% of share capital, meaning the Extraordinary General Meeting was competent to pass resolutions. Resolutions of the Extraordinary General Meeting: 1. Changes in the Supervisory Board     1) to recall Joakim Johan Helenius from the position of Supervisory Board member of Nordic Fibreboard AS;      2) to elect Rando Tomingas to the position of Supervisory Board member with the term of five (5) years as of the adoption of this resolution.The number of votes in favor of the resolution was 2 612 775 , wich is 100,00%...

GUANGZHOU, China, June 28, 2023 (GLOBE NEWSWIRE) — Burning Rock Biotech Limited (NASDAQ: BNR and LSE: BNR, the “Company” or “Burning Rock”), a company focused on the application of next generation sequencing (NGS) technology in the field of precision oncology, today announced the resignation of Dr. Shaokun (Shannon) Chuai as a director from the board of directors of the Company (the “Board”) and as the Company’s Chief Scientific Officer, effective June 30, 2023. Dr. Shaokun (Shannon) Chuai will continue to serve as a senior advisor to the Company. Dr. Zhihong (Joe) Zhang, the Company’s Chief Technology Officer since March 2016, has been appointed as a new director of the Board, effective June 30, 2023. Mr. Yusheng Han, Burning Rock’s founder, chairman of the Board and chief executive officer, commented, “We would like to take this...

Elanders will issue its report on the second quarter 2023 on Wednesday 12 July 2023, at 07:30 CET, followed by a conference call at 09:00 CET, hosted by Magnus Nilsson, President and CEO, and Andréas Wikner, CFO. We invite fund managers, analysts and the media to participate in the conference call. To join, register your details using the registration link below. Once registered, you will receive a separate email containing dial in number(s) and PINs. Register for the conference call here. Agenda08:50 Conference number is opened 09:00 Presentation of quarterly results09:20 Q&A10:00 End of the conference During the conference call a presentation will be held. To access the presentation, please use this link: https://www.elanders.com/presentations For further questions, please contactMagnus Nilsson, President and CEO, telephone: +46...

TULIKIVI CORPORATION  STOCK EXCHANGE RELEASE  28 JUNE AT 10:00 AM Tulikivi Corporation has received the following notification on 27 June 2023. Person subject to the notification requirement Name: Jouko Toivanen Position: Chief Financial Officer Issuer: Tulikivi Oyj LEI: 743700GSL41H2DXZY963 Notification type: INITIAL NOTIFICATION Reference number: 34076/4/4 ____________________________________________ Transaction date: 2023-06-27 Venue: NASDAQ HELSINKI LTD (XHEL) Instrument type: SHARE ISIN: FI0009900583 Nature of the transaction: ACQUISITION Transaction details (1): Volume: 200 Unit price: 0.470 EUR (2): Volume: 1365 Unit price: 0.479 EUR (3): Volume: 133 Unit price: 0.480 EUR (4): Volume: 1199 Unit price: 0.476 EUR (5): Volume: 1 Unit price: 0.480 EUR (6): Volume: 2102 Unit price: 0.484 EUR (7): Volume: 1408 Unit price: 0.484 EUR (8):...